Avian influenza is an infection caused by avian (bird) influenza (flu) viruses. These influenza viruses occur naturally among birds. Wild birds worldwide carry the viruses in their intestines, but usually do not get sick from them. However, avian influenza is very contagious among birds and can make some domesticated birds, including chickens, ducks, and turkeys, very sick and kill them.
Researchers have succeeded in detecting anti-avian influenza virus antibody in blood serum within 20 minutes, using a portable analyzer they have developed to conduct rapid on-site bio tests. If a suitable reagent is developed, this technology could be used to detect antibodies against SARS-CoV-2, the causative virus of COVID-19.
The SARS coronavirus 2 (SARS-CoV-2) infects lung cells and is responsible for the COVID-19 pandemic. The viral spike protein mediates entry of the virus into host cells and harbors an unusual activation sequence.
The current COVID-19 outbreak was first reported on 31 December 2019. On 11 March 2020 the World Health Organization (WHO) declared a pandemic.
Today, the National Institutes of Health will launch a new website with important educational resources for Coronavirus workers dealing with the spread of COVID-19.
When the federal government decided to investigate the threat viruses in animals posed to humans, Dennis Carroll helped lead the charge.
In the Federal State of Brandenburg, a case of highly pathogenic avian influenza (often referred to as bird flu) was found in a wild goose, caused by a virus of the H5N8 subtype.
The Hong Kong Polytechnic University today announced the development of the world's most comprehensive automated multiplex diagnostic system (the System) which includes a fully automated machine and a multiplex full-screening panel for the point-of-care genetic testing of respiratory infectious disease including the 2019-nCoV.
China has reported an outbreak of the H5N1 bird flu in Hunan, which borders the province of Hubei, the epicenter of the novel coronavirus outbreak.
A new coronavirus virus, likely first transmitted to people from animals at a market in the Chinese city of Wuhan, is making international headlines as disease detectives work to uncover what it is, how it's transmitted, and how deadly the virus actually is.
Scientists have identified the virus likely to have caused a pneumonia-like illness that has caused an outbreak in Wuhan, China.
A new study published in the journal Proceedings of the National Academy of Sciences on December 23, 2019, describes a novel device developed by a team of researchers at Penn State and New York University. Not only can this instrument capture different types of virus, it can tell what kind they are.
Normally, bird flu viruses do not spread easily from person to person. But if this does happen, it could trigger a pandemic. Researchers from the MDC and RKI have now explained in the journal Nature Communications what makes the leap from animals to humans less likely.
Now, a new study published in the journal Science on October 25, 2019, reports on a set of three novel antibodies that bind to another type of viral cell surface antigen called neuraminidase (NA) that is necessary for viral replication.
A nationwide team of researchers has found an antibody that protects mice against a wide range of potentially lethal influenza viruses, advancing efforts to design of a universal vaccine that could either treat or protect people against all strains of the virus.
Researchers have found an antibody that protects mice against a wide range of lethal influenza viruses, according to a study from Washington University School of Medicine in St. Louis, Icahn School of Medicine at Mount Sinai in New York City, and Scripps Research in La Jolla, Calif.
A new project in Northern Australia will focus on how Australia can better protect and rapidly respond to the growing global risk of emergent infectious diseases which can spread to humans through animals and insects.
The host range of the influenza A virus is restricted by dysregulated expression of the M viral gene segment, according to a study published August 15 in the open-access journal PLOS Pathogens by Anice Lowen and John Steel of Emory University School of Medicine, and colleagues.
An early-stage clinical trial is evaluating two licensed seasonal influenza vaccines, administered with or without novel adjuvants, for their safety and ability to generate an immune response.
The influenza A viruses, which have instigated deadly pandemics in the past, still remain a major global public health problem until today. Molecules known as virulence factors are produced by bacteria, viruses, and fungi to help them to infect host cells.
Dangerous airborne viruses are rendered harmless on-the-fly when exposed to energetic, charged fragments of air molecules, University of Michigan researchers have shown.